A study on the isolation period of patients with metastatic thyroid cancer treated by 131I according to a new guideline

Kakuigaku

Volumn 38, Issue 6, 2001, Pages 747-754

  Tsuchimochi, S ^a   Nakajo, M ^a   Umanodan, T ^a   Fukushima, N ^a   Shigaki, S ^a   Kiku, T ^a  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dosimetry; Iodine 131; Radiation safety; Radionuclide therapy; Thyroid cancer

Indexed keywords

IODINE 131; SODIUM DERIVATIVE;

ARTICLE; HUMAN; METASTASIS; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION EXPOSURE; RADIOACTIVITY; THYROID CANCER; THYROIDECTOMY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT ISOLATION; PRACTICE GUIDELINES; RADIATION MONITORING; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; THYROID NEOPLASMS; TIME FACTORS;

EID: 0035679864     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 131I
2. Advance in the management of patients with thyroid disease
3. Stunned thyroid after high-dose I-131 imaging
4. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy
5. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma
6. 131I
7. Iodine metabolism: Synthesis, secretion, and metabolism of thyroid hormones